In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin
Evidence suggests that the non-psychotropic phytocannabinoid cannabidiol (CBD) has anticancer activity on different cell lines and in animal models. The DNA-damaging drug epirubicin (EPI) is widely used for the treatment of malignant tumours. In this study we examined the effectiveness of CBD admini...
Guardado en:
Autores principales: | Margarita Zhelyazkova, Nadya Hristova-Avakumova, Lozan Todorov, Georgi Momekov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/561a735bda53473f927a09373311a1bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polysaccharide Cryogels Containing β-Cyclodextrin for the Delivery of Cannabidiol
por: Denitsa Momekova, et al.
Publicado: (2021) -
Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9
por: Luo Qiong, et al.
Publicado: (2021) -
Mitochondria-Targeted Nanocarriers Promote Highly Efficient Cancer Therapy: A Review
por: Zeng Zeng, et al.
Publicado: (2021) -
Sensitive and Selective Electrochemical Detection of Epirubicin as Anticancer Drug Based on Nickel Ferrite Decorated with Gold Nanoparticles
por: Mohammad Mehmandoust, et al.
Publicado: (2021) -
Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy
por: Buxant F, et al.
Publicado: (2017)